Emmanuel Katsanis

Technik-/Wissenschafts-/F&E-Leiter bei Immunovative Therapies Ltd.

Health Technology

Aktive Beziehungen

Name	Geschlecht	Alter	Unternehmensverbindungen	Zusammenarbeit
Michael Har-Noy	M	-	Immunovative Therapies Ltd. Immunovative Therapies Ltd. Pharmaceuticals: MajorHealth Technology Immunovative Therapies Ltd. develops biological drugs products. It offers AlloStim, CryoStim, Allovax, indications and animations. The firm specializes in the development of immunotherapy drug products that incorporate living immune cells as active ingredients for the treatment of cancer and infectious disease. The company was founded by Michael Har-Noy in 2004 and is headquartered in Shoham, Israel.	20 Jahre
Fred Bart Bart	M	69	Immunovative Therapies Ltd. Immunovative Therapies Ltd. Pharmaceuticals: MajorHealth Technology Immunovative Therapies Ltd. develops biological drugs products. It offers AlloStim, CryoStim, Allovax, indications and animations. The firm specializes in the development of immunotherapy drug products that incorporate living immune cells as active ingredients for the treatment of cancer and infectious disease. The company was founded by Michael Har-Noy in 2004 and is headquartered in Shoham, Israel.	24 Jahre
Steven Louis Rhodes	M	68	Immunovative Therapies Ltd. Immunovative Therapies Ltd. Pharmaceuticals: MajorHealth Technology Immunovative Therapies Ltd. develops biological drugs products. It offers AlloStim, CryoStim, Allovax, indications and animations. The firm specializes in the development of immunotherapy drug products that incorporate living immune cells as active ingredients for the treatment of cancer and infectious disease. The company was founded by Michael Har-Noy in 2004 and is headquartered in Shoham, Israel.	-
Michael Berger	M	-	Immunovative Therapies Ltd. Immunovative Therapies Ltd. Pharmaceuticals: MajorHealth Technology Immunovative Therapies Ltd. develops biological drugs products. It offers AlloStim, CryoStim, Allovax, indications and animations. The firm specializes in the development of immunotherapy drug products that incorporate living immune cells as active ingredients for the treatment of cancer and infectious disease. The company was founded by Michael Har-Noy in 2004 and is headquartered in Shoham, Israel.	-